For companies with a significant turnover or having completed a first round of seed funding, the 18-month Eurasanté acceleration programme, complementary to the Bio Incubator, allows them to accelerate their development towards Series A fundraising. These companies benefit from Eurasante’s expertise in:


  • business development in France and abroad;
  • market access;
  • financing and series A capital raising;
  • managerial and HR aspects (talent recruitment, leadership, internal organization, culture).

Are you planning clinical development and scientific cooperation in France and Europe? Is European marketing a key factor for your company’s growth and development?

Located at a busy crossroad for European businesses, the Eurasanté Bio-Acceleration Program aims to jump start medical startups and companies looking to develop in Europe. Whether you innovate in software, hardware, a service, or a combination of these, our programme will provide you with what you need to tackle the major challenges of the MedTech/Digital Health industry more effectively. Our team of experts and partners will guide you through key topics, such as value propositions, business modelling, reimbursement, IP, regulatory requirements, and much more.

contactS

Remi VERSTRAETE
Remi VERSTRAETE
Biotech
Clémentine DUFLOT
Clémentine DUFLOT
Medtech
Tania GRIGLIO
Tania GRIGLIO
Silver Eco

THEY SUPPORT US